Chen JL - Search Results

1

Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity.

Hamid MHBA, Cespedes PF, Jin C, Chen JL, Gileadi U, Antoun E, Liang Z, Gao F, Teague R, Manoharan N, Maldonado-Perez D, Khalid-Alham N, Cerundolo L, Ciaoca R, Hester SS, Pinto-Fernández A, Draganov SD, Vendrell I, Liu G, Yao X, Kvalvaag A, Dominey-Foy DCC, Nanayakkara C, Kanellakis N, Chen YL, Waugh C, Clark SA, Clark K, Sopp P, Rahman NM, Verrill C, Kessler BM, Ogg G, Fernandes RA, Fisher R, Peng Y, Dustin ML, Dong T. Hamid MHBA, et al. Among authors: chen jl, chen yl. Nat Immunol. 2024 May;25(5):834-846. doi: 10.1038/s41590-024-01802-3. Epub 2024 Apr 1. Nat Immunol. 2024. PMID: 38561495 Free PMC article.

2

Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood.

Dunbar PR, Ogg GS, Chen J, Rust N, van der Bruggen P, Cerundolo V. Dunbar PR, et al. Curr Biol. 1998 Mar 26;8(7):413-6. doi: 10.1016/s0960-9822(98)70161-7. Curr Biol. 1998. PMID: 9545200 Free article.

3

High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo.

Ogg GS, Rod Dunbar P, Romero P, Chen JL, Cerundolo V. Ogg GS, et al. Among authors: chen jl. J Exp Med. 1998 Sep 21;188(6):1203-8. doi: 10.1084/jem.188.6.1203. J Exp Med. 1998. PMID: 9743539 Free PMC article.

4

Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma.

Dunbar PR, Chen JL, Chao D, Rust N, Teisserenc H, Ogg GS, Romero P, Weynants P, Cerundolo V. Dunbar PR, et al. Among authors: chen jl. J Immunol. 1999 Jun 15;162(12):6959-62. J Immunol. 1999. PMID: 10358133

5

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.

Chen JL, Dunbar PR, Gileadi U, Jäger E, Gnjatic S, Nagata Y, Stockert E, Panicali DL, Chen YT, Knuth A, Old LJ, Cerundolo V. Chen JL, et al. Among authors: chen yt. J Immunol. 2000 Jul 15;165(2):948-55. doi: 10.4049/jimmunol.165.2.948. J Immunol. 2000. PMID: 10878370

6

Competition between CTL narrows the immune response induced by prime-boost vaccination protocols.

Palmowski MJ, Choi EM, Hermans IF, Gilbert SC, Chen JL, Gileadi U, Salio M, Van Pel A, Man S, Bonin E, Liljestrom P, Dunbar PR, Cerundolo V. Palmowski MJ, et al. Among authors: chen jl. J Immunol. 2002 May 1;168(9):4391-8. doi: 10.4049/jimmunol.168.9.4391. J Immunol. 2002. PMID: 11970981

7

Antigen potency and maximal efficacy reveal a mechanism of efficient T cell activation.

Dushek O, Aleksic M, Wheeler RJ, Zhang H, Cordoba SP, Peng YC, Chen JL, Cerundolo V, Dong T, Coombs D, van der Merwe PA. Dushek O, et al. Among authors: chen jl. Sci Signal. 2011 Jun 7;4(176):ra39. doi: 10.1126/scisignal.2001430. Sci Signal. 2011. PMID: 21653229 Free PMC article.

8

NOD2 and TLR2 Signal via TBK1 and PI31 to Direct Cross-Presentation and CD8 T Cell Responses.

Corridoni D, Shiraishi S, Chapman T, Steevels T, Muraro D, Thézénas ML, Prota G, Chen JL, Gileadi U, Ternette N, Cerundolo V, Simmons A. Corridoni D, et al. Among authors: chen jl. Front Immunol. 2019 Apr 30;10:958. doi: 10.3389/fimmu.2019.00958. eCollection 2019. Front Immunol. 2019. PMID: 31114588 Free PMC article.

9

Self-Maintaining CD103⁺ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses.

Abd Hamid M, Colin-York H, Khalid-Alham N, Browne M, Cerundolo L, Chen JL, Yao X, Rosendo-Machado S, Waugh C, Maldonado-Perez D, Bowes E, Verrill C, Cerundolo V, Conlon CP, Fritzsche M, Peng Y, Dong T. Abd Hamid M, et al. Among authors: chen jl. Cancer Immunol Res. 2020 Feb;8(2):203-216. doi: 10.1158/2326-6066.CIR-19-0554. Epub 2019 Nov 26. Cancer Immunol Res. 2020. PMID: 31771983 Free PMC article.

10

Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells.

Prota G, Gileadi U, Rei M, Lechuga-Vieco AV, Chen JL, Galiani S, Bedard M, Lau VWC, Fanchi LF, Artibani M, Hu Z, Gordon S, Rehwinkel J, Enríquez JA, Ahmed AA, Schumacher TN, Cerundolo V. Prota G, et al. Among authors: chen jl. Cancer Immunol Res. 2020 May;8(5):685-697. doi: 10.1158/2326-6066.CIR-19-0467. Epub 2020 Mar 23. Cancer Immunol Res. 2020. PMID: 32205315

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,511 results

Search Page

Filters